Symyx Technologies Announces Deployment of Symyx Renaissance Software at Pfizer
Symyx Technologies, Inc. (Nasdaq: SMMX) today announced that Pfizer Inc.’s Global Chemical Research and Development (CRD) group is deploying Symyx Renaissance® electronic laboratory notebook (ELN) software. This agreement extends and expands an existing software license to all major Pfizer CRD sites within the pharmaceutical sciences organization.
About Symyx Renaissance Software
- Electronic laboratory notebook software that provides uniform IP protection and project data management across the enterprise, along with tailored user interfaces offering immediate direct benefit to scientists in medicinal chemistry as well as pharmaceutical and chemical development
- Experimental design and broad data capture capability applicable to conventional and automated research
- Flexible, vendor-independent laboratory automation for automated research
- Enterprise-wide real time data warehousing, querying and reporting to support effective and timely decision-making
Over 40 organizations around the world use Symyx software, including many leading pharmaceutical, biotech and chemical companies.
About Symyx
Symyx Technologies, Inc. is dedicated to helping customers maximize the effectiveness and success of their research & development programs. Symyx develops and applies high-throughput research technologies and research software for customers in the pharmaceutical, chemical, energy, electronics and other industries. Symyx performs research for customers using proprietary technologies to discover new and innovative materials, sells automated high-throughput instrumentation and licenses software for use in customers’ own laboratories, and licenses discovered materials, sensors and intellectual property. Symyx has the largest portfolio of patents in the field of high-throughput materials discovery, with 280 issued patents and 370 patent applications on file worldwide. Information about Symyx, including reports and other information filed by Symyx with the Securities and Exchange Commission, is available at www.symyx.com .
